
Highlights from IKCS 2020 and the Virtual Patient Symposium
Event
Below, we've linked highlights from research presented at IKCS 2020, the KCA’s fall symposium, which took place on November 6-7, as well as selections from the KCA’s first annual Virtual Patient Symposium on November 7. IKCS 2020 Cabozantanib is the center of emerging treatment approaches in advanced RCC - OncLive Frontline lenvatinib/everolimus combo is active in non-clear cell RCC -…
Read More